Extremely Severe Complicated Spastic Paraplegia 3A With Neonatal Onset

Hedera P. Spastic paraplegia 3A. In: Pagon RA, Adam MP, Bird TD, et al. (ed) GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle, 1993-2014. Available at: http://www.ncbi.nlm.nih.gov/books. Accessed March 24, 2014. Byrnes, 2011, Structural basis for the nucleotide-dependent dimerization of the large G protein atlastin-1/SPG3A, Proc Natl Acad Sci USA, 108, 2216, 10.1073/pnas.1012792108 Bian, 2011, Structures of the atlastin GTPase provide insight into homotypic fusion of endoplasmic reticulum membranes, Proc Natl Acad Sci USA, 108, 3976, 10.1073/pnas.1101643108 HGMD mutation result. Available at: http://portal.biobase-international.com/hgmd. Accessed February 14, 2014. Rainier, 2006, De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy, Arch Neurol, 63, 445, 10.1001/archneur.63.3.445 Ivanova, 2007, Hereditary spastic paraplegia 3A associated with axonal neuropathy, Arch Neurol, 64, 706, 10.1001/archneur.64.5.706 Dalpozzo, 2003, Infancy onset hereditary spastic paraplegia associated with a novel atlastin mutation, Neurology, 61, 580, 10.1212/01.WNL.0000078189.73611.DF Hedera, 2004, Novel mutation in the SPG3A gene in an African American family with an early onset of hereditary spastic paraplegia, Arch Neurol, 61, 1600, 10.1001/archneur.61.10.1600 Fusco, 2010, Hereditary spastic paraplegia and axonal motor neuropathy caused by a novel SPG3A de novo mutation, Brain Dev, 32, 592, 10.1016/j.braindev.2009.08.003 Fusco, 2012, Very early onset and severe complicated phenotype caused by a new spastic paraplegia 3A gene mutation, J Child Neurol, 27, 1348, 10.1177/0883073811435245 Haberlová, 2008, Extending the clinical spectrum of SPG3A mutations to a very severe and very early complicated phenotype, J Neurol, 255, 927